HYPERTENSION NMP. How Common? 25% UK adults 25% UK adults > 50% adults over 60 > 50% adults over 60.

Slides:



Advertisements
Similar presentations
2 cases of hypertension Year 1 Michaelmas term 2006.
Advertisements

CE REVIEW UNDERSTANDING HYPERTENSION. Hypertension is a chronic medical condition affecting more than 65 million Americans. Controlling hypertension is.
SHAHKUR SHABIR GP REGISTRAR DR ELLA RUSSELL -GP TRAINER SUNNYBANK MEDICAL CENTRE OCT 2011.
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
Prescribing in Chronic Renal Disease. Who has chronic renal disease (CKD)? CKD stages 1-V How common is it? Creatinine v GFR Basic Principles Scenarios.
BACK TO BASICS: PHARMACOLOGY CHAD C. CRIPE, MD Department of Anesthesiology & Critical Care Medicine Division of Cardiothoracic Anesthesiology The Children’s.
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
JNC 8 Guidelines….
National Institute for Health and Clinical Excellence.
Chronic Kidney Disease NICE Guidelines 2008 Dr Jennifer Kuo Dr Naeema Rashid Dr Shamita Das.
Assessment and Management of Patients With Hypertension.
The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure
For A Healthy Heart: Blood Pressure Management Presented by: Daniel Schimmel, MD, MS Assistant Professor of Medicine, Cardiology Bluhm Cardiovascular Institute.
Hypertension – Summary
 Cure Pathologic Fear of Hypertension  Create Rational Approach to Drug Choice  Complement Rational Choice with Pearls  Consolidate new information.
The Renin-Angiotensin- Aldosterone System MATT VREUGDE
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 9 th Lecture.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Managing hypertension in primary care
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Antihypertensives Chad Byworth. Hypertension What is hypertension? Blood pressure of greater than 140 systolic or 90 diastolic, confirmed in primary care.
Pharmacological Treatment of Hypertension Update 2012.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Drugs for Hypertension
Indication:  Suspected Heart Failure With abnormal ECG or Intermediate BNP ( ) BNP:  Asymptomatic Murmur  Asymptomatic Cardiomegaly On CXR Direct.
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
NICE Guideline Synopsis. Definitions Stage 1 Hypertension Clinic BP 140/90 or higher And ABPM Daytime average/HBPM 135/85 or higher.
Drugs Acting on the Renin-Angiotensin-Aldosterone System
Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal
 Hypertension : BPDIASTOLIC SYSTOLIC Normal< 130< 85 Mild hypertension Moderate hypertension Severe Hypertension 180.
CARDIOVASCULAR MODULE: HYPERTENSION Adult Medical-Surgical Nursing.
1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
Antihypertensives Dr Thabo Makgabo.
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
Pharmacology of Heart failure
Primary care team meeting Hypertension Dr Som Desilva.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
HYPERTENSION RECOMMENDATIONS FOR FOLLOW UP BASED ON INITIAL BP READING
Source: Your Guide To Lowering Blood Pressure, Pathophysiology BMS 243 Hypertension Dr. Aya M. Serry 2015/2016.
Diuretics and Antihypertensives
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
Effect of some adrenergic drugs and its blockers on the blood pressure.
Presented by: Sara Khalid Memon – Group B3 3 rd year, MBBS, LUMHS.
Janice Herbert-Carter, MD, MGA, FACP Associate Professor of Medical Education.
Prescribing in cardiovascular disease By Jole Hannan Medicines Optimisation Pharmacist.
MEDICINES & THE HEART. Medicines & the Heart You and your medicines You and your medicines Common heart medicines for preventing heart disease Common.
Internal Medicine Workshop Series Laos September /October 2009.
Hypertension Dept. of Pharmacology Faculty of Medicine & Health Sciences AIMST.
Drugs for Hypertension
Hypertension in primary care
Clinical Management of primary hypertension
Diuretics Thiazides are the preferred type of diuretic for treating hypertension, and all are equally effective in lowering blood pressure. In patients.
Drugs for Hypertension
HTN Cases Pharmacotherapy - 1.
THE SILENT KILLER HYPERTENSION.
Hypertension: A Risk Factor For Stroke
UNIT 2: ANTIHYPERTENSIVE DRUGS
UNIT 2: ANTIHYPERTENSIVE DRUGS
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.
Drugs Acting on the Renin-Angiotensin-Aldosterone System
Essential Hypertension
Chapter 32 Assessment and Management of Patients With Hypertension
Pharmacological Treatment of Hypertension Update 2012
Internal Medicine Workshop Series Laos September /October 2009
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.
Presentation transcript:

HYPERTENSION NMP

How Common? 25% UK adults 25% UK adults > 50% adults over 60 > 50% adults over 60

Hypertension: the silent killer Asymptomatic Asymptomatic Not associated with Not associated with –Headaches –nosebleeds

Complications CVA CVA MI MI CCF CCF CKD CKD PVD PVD Cognitive decline Cognitive decline Premature death Premature death Depends on ethnicity Depends on ethnicity Cf diabetes Cf diabetes

Treatment Life style Life style Drugs Drugs Rarely surgery Rarely surgery –Bariatric surgery –Endocrine surgery –Renal artery angioplasty –Renal denervation

NICE guidelines Aug 2011 Primary care Primary care Excludes Excludes –Diabetes –18 yrs –pregnancy

3 Stages of hypertension 1 clinic BP >140/90 1 clinic BP >140/90 –ABPM is >135/85 2 clinic BP >160/100 2 clinic BP >160/100 –ABPM >150/95 3 SEVERE BP>180/110 3 SEVERE BP>180/110

ABPM Do not start treatment without ABPM unless severe hypertension ie 180/110 Do not start treatment without ABPM unless severe hypertension ie 180/110 Monitor about half the size of the BNF Monitor about half the size of the BNF Home monitoring an alternative but much less data Home monitoring an alternative but much less data Huge resource implications Huge resource implications ?? Save money ?? Save money

Who To Treat? Stage 1 Stage 1 –Under 80 –Target organ damage –Established cardiovascular disease –Renal disease –Diabetes –10 year cardiovascular risk>20% –Think about under 40 Stage 2 treat Stage 2 treat

Relearn your alphabet No longer ABCD No longer ABCD Now ACDD Now ACDD

Step 1 Under 55 Under 55 –A ACE or ARB Ramipril, perindopril Ramipril, perindopril Losarten irbesarten candasarten Losarten irbesarten candasarten –C Over 55, or African or carribean C calcium channel blocker C calcium channel blocker –Amlodipine

Step 2 Add A to C Add A to C

Step 3 Add A to C to D Add A to C to D Now using thiazide like diuretics NOT bendroflumethazide or hydrochlorothiazide Now using thiazide like diuretics NOT bendroflumethazide or hydrochlorothiazide Indapamide or chlortalidone Indapamide or chlortalidone

Step 4 Add in further diuretic Add in further diuretic D Spironolactone D Spironolactone –If Potassium <4.5 –NB low GFR Increase dose of non thiazide Increase dose of non thiazide

Step 5 Free for all Free for all ? Refer ? Refer ? Alpha blocker ? Alpha blocker ? Beta blocker ? Beta blocker

Own Goals Spironolactone does not have a product license for hypertension Spironolactone does not have a product license for hypertension Recommended dose of chlortalidone is 12.5 or 25 and only 50 mg is available. Recommended dose of chlortalidone is 12.5 or 25 and only 50 mg is available.

Pharmacology ACE/ARB ACE 10-20% will have a dry cough ACE 10-20% will have a dry cough ARB is an ACE without the dry cough and without angio oedema ARB is an ACE without the dry cough and without angio oedema First dose hypotension First dose hypotension Bilateral renal artery stenosis Bilateral renal artery stenosis –Worsening U and E High potassium High potassium

Renin angiotensin system Low BP Renin excretion from kidney (enzyme) Angiotensinogen Angiotensin 1 Angiotensin II Inc. aldosterone from adrenals Retention of salt and water from kidney Vasoconstriction Renal retention of salt and water ACE-I Spironalactone ARBs Renin inhibitor

Calcium channel blockers Usually amlodipine but I also use diltiazem and verapamil Usually amlodipine but I also use diltiazem and verapamil Main side effect is ankle oedema with amlodipine Main side effect is ankle oedema with amlodipine –Swop to verapamil or diltiazem –Lower the dose. Try 2.5mg Gum hyperplasia Gum hyperplasia Drug interaction with simvastatin Drug interaction with simvastatin

Spironolactone (Potassium sparing diuretic) (Potassium sparing diuretic) Aldosterone antagonist Aldosterone antagonist Oestrogen like side effects Oestrogen like side effects Gynacomastia and high potassium Gynacomastia and high potassium

Chronic diseases No decision about me without me No decision about me without me

Case study 32 year old city worker 32 year old city worker Presented to GP with headaches Presented to GP with headaches Found to be hypertensive Found to be hypertensive

Referred to a neurologist Referred to a neurologist No cause found for headaches No cause found for headaches Multiple intolerances to BP drugs Multiple intolerances to BP drugs Referred to hypertensive clinic Referred to hypertensive clinic

Full history and examination Full history and examination BP 165/104 BP 165/104 Confirmed on ABPM Confirmed on ABPM Amlodipine 5 mg started Amlodipine 5 mg started

Comes back 4 weeks later complaining of a headache Comes back 4 weeks later complaining of a headache Stopped Amlodipine Stopped Amlodipine BP still high BP still high

Explained that he always has headaches and no serious cause found Explained that he always has headaches and no serious cause found If BP remains high he is at risk of CVA/MI If BP remains high he is at risk of CVA/MI Asked him want he wanted to do Asked him want he wanted to do

I will take the amlodipine I will take the amlodipine

Non Pharmacological management This has not changed This has not changed Alcohol Alcohol Smoking Smoking Diet Diet –Decrease caffeine –decrease salt –(5 a day) –(Low fat dairy products) –Wt loss if appropriate –Exercise

Summary Down load new guidelines Down load new guidelines NB Amlodipine and Simvastatin NB Amlodipine and Simvastatin No decision about me without me. No decision about me without me.